Acute Lymphocytic Leukemia New Prognosis Factors

Dra Mirta D’ambra*

Received: June 25, 2018;   Published: July 03, 2018

DOI: 10.26717/BJSTR.2018.06.001329

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

It is the most common adult leukemia in the western world. Its complexity has increased as a result of the advent of new biological agents, the identification of molecular predictive markers and the introduction of more sensitive and sophisticated techniques evaluate minimal residual disease. The western world, CLL accounts for almost 25% of all leukemias and 1.3% of all cancers. Its incidence is substantially lower among Asian people and higher among Ashkenazi Jews. It is estimated that its incidence will continue its upward trend. It affects mainly elderly people, (more than 70% are> 65 years, the median age at diagnosis is 72 years). Men and white people are more frequently affected than women and other races.

Short Communication| Introduction| Materials and Methods| Results| Discussion| Conclusion| Acknowledgement|